A Two-stage Simon Design Phase II Study for Non-BRCA MBC Patients With HRD Treated With Olaparib Single Agent

NCT03367689 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
7
Enrollment
OTHER
Sponsor class

Stopped Very slow recruitment due to subject profile

Conditions

Interventions

Sponsor

MedSIR